
Adsunib 50 Capsule
Marketer
Adley Formulations
Salt Composition
Sunitinib (50mg)
Overview Adsunib 50 Capsule
Axitinib 50mg capsules treat kidney and gastrointestinal stromal tumors by inhibiting enzymes crucial for cancer cell proliferation, thereby reducing tumor size and growth rate. This medication can be administered with or without food, but consistent daily timing optimizes efficacy. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is vital; improper use or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Frequent side effects include fatigue, loose stools, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring is often recommended. Axitinib can lower blood glucose, potentially causing hypoglycemia and fainting; diabetics should monitor blood sugar levels carefully and adjust anti-diabetic medication as needed under medical guidance. Inform your doctor about pre-existing heart, liver, kidney, or bleeding disorders before commencing treatment. Interactions with other medications are possible; disclose all current medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Uses of Adsunib 50 Capsule
Kidney and gastrointestinal stromal tumor therapies
Major Benefits of Adsunib 50 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Adsunib 50mg capsules can be administered with or without food, though consistent timing is recommended.
Common Side effects of Adsunib 50 Capsule:
- Hand-foot syndrome
- Bleeding disorder
- Low blood platelets
- Decreased appetite
- Nausea
- Vomiting
- Weakness
- Abdominal pain
- Indigestion
- High blood pressure
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Taste change
How to use Adsunib 50 Capsule:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Adsunib 50mg capsules can be administered with or without food; however, consistent timing is recommended.
How Adsunib 50 Capsule works:
Adsunib 50mg capsules are an anti-neoplastic agent. Their mechanism of action involves inhibiting specific tyrosine kinase receptors on cancer cells, thereby halting their proliferation. The drug also suppresses angiogenesis, limiting the tumor's blood supply and further restricting cancerous growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Adsunib 50 Capsule has unknown safety implications. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Adsunib 50 Capsule during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Adsunib 50 Capsules while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Adsunib 50 Capsules might lead to side effects that impair driving ability. Dizziness is a possible side effect. Refrain from driving or operating machinery if dizziness occurs during treatment.
KidneySAFE IF PRESCRIBED
Adsunib 50mg capsules can be administered to patients with renal impairment without the need for dosage modification.
LiverSAFE IF PRESCRIBED
Adsunib 50mg capsules may be administered to patients with hepatic impairment without alteration of the prescribed dosage.
What if you forget to take Adsunib 50 Capsule :
Omit any missed Adsunib 50 Capsule dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Adsunib 50 Capsule
| Label | Value |
|---|---|
| Type of Compound | Indole- and pyrrole-containing compounds |
| Addictive | None. |
| Medication Category | Cancer-fighting drugs |
